Technical Analysis for TNGX - Tango Therapeutics
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 8.41 | 1.57% | 0.13 |
TNGX closed up 1.57 percent on Thursday, September 19, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Calm After Storm | Range Contraction | 1.57% | |
| NR7 | Range Contraction | 1.57% | |
| Lower Bollinger Band Walk | Weakness | 1.57% | |
| Stochastic Reached Oversold | Weakness | 1.57% |
| Alert | Time |
|---|---|
| Down 1% | about 2 hours ago |
| Fell Below Previous Day's Low | about 3 hours ago |
| Possible NR7 | about 4 hours ago |
| Possible Inside Day | about 4 hours ago |
| 60 Minute Opening Range Breakdown | about 4 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/05/2024
Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Biology Treatment Of Cancer Tumor Genetics Medical Genetics Applied Genetics Synthetic Lethality Oncogenomics
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Biology Treatment Of Cancer Tumor Genetics Medical Genetics Applied Genetics Synthetic Lethality Oncogenomics
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.03 |
| 52 Week Low | 5.15 |
| Average Volume | 899,662 |
| 200-Day Moving Average | 9.40 |
| 50-Day Moving Average | 9.91 |
| 20-Day Moving Average | 10.40 |
| 10-Day Moving Average | 9.43 |
| Average True Range | 0.97 |
| RSI (14) | 39.02 |
| ADX | 24.6 |
| +DI | 18.67 |
| -DI | 28.14 |
| Chandelier Exit (Long, 3 ATRs) | 9.11 |
| Chandelier Exit (Short, 3 ATRs) | 10.94 |
| Upper Bollinger Bands | 12.73 |
| Lower Bollinger Band | 8.07 |
| Percent B (%b) | 0.07 |
| BandWidth | 44.79 |
| MACD Line | -0.35 |
| MACD Signal Line | -0.03 |
| MACD Histogram | -0.3134 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.19 | ||||
| Resistance 3 (R3) | 9.19 | 8.93 | 9.06 | ||
| Resistance 2 (R2) | 8.93 | 8.73 | 8.93 | 9.02 | |
| Resistance 1 (R1) | 8.67 | 8.61 | 8.54 | 8.67 | 8.97 |
| Pivot Point | 8.41 | 8.41 | 8.35 | 8.41 | 8.41 |
| Support 1 (S1) | 8.15 | 8.21 | 8.02 | 8.15 | 7.85 |
| Support 2 (S2) | 7.89 | 8.09 | 7.89 | 7.80 | |
| Support 3 (S3) | 7.63 | 7.89 | 7.76 | ||
| Support 4 (S4) | 7.63 |
